The evaluation of the effect of tafluprost on the intraocular pressure of healthy male guinea pigs under different light-and-darkness regimes

Vet Med Sci. 2023 May;9(3):1172-1178. doi: 10.1002/vms3.1082. Epub 2023 Feb 9.

Abstract

Background: Ocular hypertension is one of the most underdiagnosed ocular abnormalities among guinea pigs around the world.

Objectives: The current study investigates the effect of 0.0015% preservative-free tafluprost ophthalmic solution (Zioptan) on the intraocular pressure of 16 healthy male guinea pigs (Cavia porcellus) under different light/darkness regimes.

Methods: All guinea pigs received a single drop of tafluprost at 5:30 in the right eye, whereas the contralateral eyes served as control to receive a placebo. Then, the animals were randomly divided into two groups; group A was exposed to light, whereas group B was placed in darkness from 5:30 to 18:00. Rebound tonometry (TonoVet) was instrumented to measure IOP values at 5:30 (baseline), 6:00, 7:00, 8:00, 9:00 and then every 3 h until 18:00.

Results: The maximum IOP reduction associated with tafluprost was observed at 6:00 by -1.4 ± 1.1 mmHg (p-value = 0.026) and -2.5 ± 1.2 mmHg (p-value = 0.011) in group A and B, respectively (repeated measure ANOVA test). There was a significant difference between the mean right and left eye IOP values in both groups at 5:30, 6:00, 7:00 and 8:00 (p-value <0.05), which was greater in amount in group B compared to group A due to the effect of darkness on IOP reduction.

Conclusions: It is suggested that the variations of IOP in different light/dark conditions be taken into consideration when applying ocular hypotensive agents on guinea pigs' eyes.

Keywords: glaucoma; guinea pig; intraocular pressure; light; ocular hypertension; tafluprost.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Animals
  • Darkness
  • Guinea Pigs
  • Intraocular Pressure*
  • Male
  • Prostaglandins F / pharmacology
  • Prostaglandins F / therapeutic use
  • Tonometry, Ocular* / veterinary

Substances

  • tafluprost
  • Prostaglandins F